Innovations in Ever-Evolving Landscape of the Acne Treatment Market

Acne is a skin disorder that is very common and that is caused by the clogging up of hair follicles with sebum and dead skin cells which results in acne also sometimes referred to as whiteheads or blackheads but in some cases deeper lesions such as nodules. Acne mostly on the face, chest, back and upper part of the body. The condition occurs more commonly among people between the ages of 14 to 30 years. In addition, it has been linked with hormonal imbalances during puberty. Various methods and goods have been developed specifically to combat and tone down on acne and form the bulk of anti-acne therapies. The intensity of this skin disease and the remedies that are used to counter its emergence is quite varied since some forms are treatable through over-the-counter topical medicine while others require prescribed drugs or chemical peels/laser therapy Conversely, a person who wants help or advice about how to control pimples would turn to dermatologists’ clinics as well as med-esthetician’s parlour or even pharmacies mainly based on the internet. The healthcare industry is greatly aided by clinical approvals and drug launches; the acne treatment market is no exception. The introduction of new medicines and therapies has altered the treatment scenario for acne giving a wider range of choices to patients and physicians. For instance, In July 2022, the MINYM brand name was used by Glenmark Pharmaceuticals to release the first Minocycline 4% Gel for treatment of moderate to severe acne. Minocycline is a powerful antibacterial gel that possesses a clear anti-inflammatory effect. It has the least amount of MIC90 in comparison with other topical antimicrobial agents. formulations. formulations. Global Production Trends Retinoids are a class of compounds that either chemically resemble or are derived from vitamin A. They are involved in the regulation of cell growth and differentiation, among other biological processes. Since retinoids interact with the skin, dermatologists widely apply them in therapy. The improvement of wrinkles as well as hyperpigmentation serves as evidence of the effect of retinoids on photoaging. Furthermore, retinoids stimulate cell turnover and alter cell behaviour in skin cells by attaching to particular receptors in the cells. This product reduces hyperpigmentation, encourages the production of collagen, and clears out pore obstructions. Because of their primary medicinal properties and the pending approvals of future medications, retinoid is expected to lead the market as the leading innovator. Acne Treatment Use Case Since acne treatments are of high doses patients are advised for a topical route of administration This is mainly because of its direct application to the impacted area, low systemic side effects, and improved accessibility and convenience. The need for less intrusive methods of treating acne has grown over the last few decades. Topical medications are often the first choice for treating acne because they are easily obtainable, very effective, and have minimal adverse effects. There are several topical treatments available, such as lotions, gels, and creams containing salicylic acid, benzoyl peroxide, vitamin A analogue solutions, and creams. The acne treatment market has expanded because of the availability of dermatological clinics. Such clinics play a significant role in enhancing the growth of the Acne treatment industry with various strategies like medication, therapy and cosmetic procedures being offered to patients suffering from the condition. This treatment aims not only at curing it but also making life better for those who suffer from this condition through specialized healthcare. Moreover, the need for less intrusive methods of treating acne has grown over the last few decades. Topical medications are often the first choice for treating acne because they are easily obtainable, very effective, and have minimal adverse effects. There are several topical treatments available, such as lotions, gels, and creams containing salicylic acid, benzoyl peroxide, vitamin A analog solutions, and creams. Market Dynamics and Drivers Acne is a common dermatological condition, affecting approximately 9.4% of the global population in 2022. It is the most common disease in the world and the most common among skin conditions. Around 95% of people between the ages of 11 and 30 have had acne at some point in their lives.  The majority of people with acne are teenagers and young adults. Approximately 80% of teenagers worldwide suffer from acne, with 20% of those affected by moderate to severe forms of the disorder. Furthermore, the prevalence of adult acne is estimated to be 40% of the population currently indicating a growing issue. Acne often has major psychosocial consequences even though it may not directly pose a threat to a person’s life. Acne is more common in urban areas for women and people with oily skin but its prevalence varies by region gender ethnicity and lifestyle. Acne is also becoming more common which can be attributed to a variety of factors including hormonal fluctuations dietary choices pharmaceutical use stress environmental pollution and genetic predisposition. Figure 1: Acne Severity, Men & Women, in Percentage, 2024 Source: Jaad.org Moreover, it is anticipated that the existence of advantageous regulatory frameworks that expedite the approval and market introduction of innovative anti-acne drugs will create prospects for market growth. The US FDA agency gave Zydus Lifesciences final clearance in June 2022 to sell Adapalene with Benzoyl Peroxide Topical Gel 0.3%/2.5% for commercial use. By combining skin-peeling agent Benzoyl Peroxide with retinoid Adapalene the gel reduces the quantity and severity of acne lesions. In this gel adapalene functions by regulating cell proliferation and reducing swelling and inflammation. Moreover, benzoyl peroxide causes skin to become dry and exfoliate while decreasing the quantity of bacteria that cause acne. Key Developments

• In June 2023, Hyundai Pharmaceutical Co., Ltd. and Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) announced the signing of a license agreement for Winlevi® (clascoterone) cream 0.1% in the Republic of Korea. The US Food and Drug Administration (FDA) has approved Winlevi® as a novel medication with a distinct mode of action for the topical treatment of acne in patients 12 years of age and older. This novel mechanism of action for acne is the first to be approved by the FDA in forty years. It is a topical androgen receptor inhibitor that addresses the androgen hormone component of acne.
• In January 2022, Journey Medical Corporation purchased the Stabilizing Technology (MST) Franchise and two topical minocycline products approved by the Food and Drug Administration from VYNE Therapeutics, Inc. AMZEEQ is a product in this franchise that treats acne.
• In May 2023, the US Food and Drug Administration (FDA) accepted the New Drug Application (NDA) for IDP-126, which is being investigated, as of May 2023, according to a statement made by Bausch Health Companies Inc. and Ortho Dermatologics, a dermatology subsidiary.

In conclusion, the acne treatment market presents significant opportunities for growth and innovation, driven by the increasing popularity of clear skin. While facing challenges such as fluctuation in material costs that negatively affect various industry verticals and huge investments for research and development for new and innovative acne treatment methods with no side-affects, the industry is poised to capitalize on technological advancements and innovations to meet the needs of a growing global demand for acne treatment market. Find some of our related studies:

• Skincare Serums Market: https://www.knowledge-sourcing.com/report/skincare-serums-market
• CBD Skincare Market: https://www.knowledge-sourcing.com/report/cbd-skincare-market
• Global Skin Care Market: https://www.knowledge-sourcing.com/report/global-skin-care-market

 

Subscribe Us